Back to Top
Patritumab Deruxtecan Biosimilar - Research Grade
Add recommended extras
Patritumab Deruxtecan Biosimilar - Research Grade
| Species Reactivity | Human |
|---|---|
| Target | ERBB3 / HER3 |
| Concentration | 1mg/ml |
| Isotype | IgG1 |
| Host | CHO Cells |
| Shipping Conditions | Room Temp |
| background | Anti-ERBB3/ HER3 Reference Antibody (Patritumab deruxtecan) is a novel ADC composed of an anti-HER3 antibody (Patritumab) and a novel potent topoisomerase I inhibitor DX-8951,conjugated, on an average of 8 cysteinyl, to deruxtecan, comprising a linker and |
| Other names | Dxd |
| Formulation | 25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2) |
| Purity | >90% by SDS-PAGE |
| Storage | This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C. |
| Applications | Functional Assays |
| Application Notes | Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex. |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Delivery Time | 1 week |
Write Your Own Review
Who Viewed This Also Viewed
Anti-Mouse GITR (DTA-1) In Vivo Antibody - Low Endotoxin
$400.00 - $2,945.00
Anti-Mouse TIGIT (1G9) In Vivo Antibody - Low Endotoxin
$400.00 - $2,945.00
